Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1361626
                    [Title] => Astrazeneca’s new medication for type 2 diabetes
                    [Summary] => 
AstraZeneca recently launched its new once-daily oral medication to aid Filipino adult patients with type 2 diabetes manage their condition better through the removal of excess glucose and its associated calories in the urine.

                    [DatePublished] => 2014-08-26 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 926544
                    [Title] => Experts highlight vildagliptin’s novel mechanism of action
                    [Summary] => 
With their novel mechanism of action, DPP-4 inhibitors such as vildagliptin are an excellent addition to currently available oral treatments for type 2 diabetes.

                    [DatePublished] => 2013-04-04 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 5103
                    [Title] => Palace declares July 20 PAD Awareness Day
                    [Summary] => 
            
                    [DatePublished] => 2007-07-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. ARACELI PANELO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1361626
                    [Title] => Astrazeneca’s new medication for type 2 diabetes
                    [Summary] => 
AstraZeneca recently launched its new once-daily oral medication to aid Filipino adult patients with type 2 diabetes manage their condition better through the removal of excess glucose and its associated calories in the urine.

                    [DatePublished] => 2014-08-26 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 926544
                    [Title] => Experts highlight vildagliptin’s novel mechanism of action
                    [Summary] => 
With their novel mechanism of action, DPP-4 inhibitors such as vildagliptin are an excellent addition to currently available oral treatments for type 2 diabetes.

                    [DatePublished] => 2013-04-04 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 5103
                    [Title] => Palace declares July 20 PAD Awareness Day
                    [Summary] => 
            
                    [DatePublished] => 2007-07-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Astrazeneca’s new medication for type 2 diabetes

August 26, 2014 - 12:00am

AstraZeneca recently launched its new once-daily oral medication to aid Filipino adult patients with type 2 diabetes manage their condition better through the removal of excess glucose and its associated calories...

Health And Family

Experts highlight vildagliptin’s novel mechanism of action

April 4, 2013 - 12:00am

With their novel mechanism of action, DPP-4 inhibitors such as vildagliptin are an excellent addition to currently available oral treatments for type 2 diabetes.

Science and Environment

Palace declares July 20 PAD Awareness Day

July 12, 2007 - 12:00am

Science and Environment